DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0011849 | Diabetes Mellitus | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0020456 | Hyperglycemia | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0011847 | Diabetes | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0030567 | Parkinson Disease | INPP5F | 22876 | inositol polyphosphate-5-phosphatase F | Q9Y2H2 |
C0796012 | Krause-Kivlin syndrome | POFUT2 | 23275 | protein O-fucosyltransferase 2 | Q9Y2G5 |
C0036341 | Schizophrenia | POFUT2 | 23275 | protein O-fucosyltransferase 2 | Q9Y2G5 |
C0024530 | Malaria | POFUT2 | 23275 | protein O-fucosyltransferase 2 | Q9Y2G5 |
C0282577 | Congenital Disorders of Glycosylation | POFUT2 | 23275 | protein O-fucosyltransferase 2 | Q9Y2G5 |
C0265259 | Popliteal pterygium syndrome | POFUT2 | 23275 | protein O-fucosyltransferase 2 | Q9Y2G5 |
C0038454 | Cerebrovascular accident | MAN2B2 | 23324 | mannosidase alpha class 2B member 2 | Q9Y2E5 |
C0021051 | Immunologic Deficiency Syndromes | MAN2B2 | 23324 | mannosidase alpha class 2B member 2 | Q9Y2E5 |
C0265343 | Jarcho-Levin syndrome | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0036572 | Seizures | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0036439 | Scoliosis, unspecified | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C3714756 | Intellectual Disability | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0025958 | Microcephaly | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0000768 | Congenital Abnormality | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0085136 | Central Nervous System Neoplasms | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0004352 | Autistic Disorder | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0029422 | Osteochondrodysplasias | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0282577 | Congenital Disorders of Glycosylation | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C1510586 | Autism Spectrum Disorders | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0017638 | Glioma | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0036857 | Severe intellectual disability | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0014544 | Epilepsy | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024